±±¾©Ê¯ÓÍ»¯¹¤Ñ§Ôº2026ÄêÑо¿ÉúÕÐÉú½ÓÊÕµ÷¼Á¹«¸æ
²é¿´: 754  |  »Ø¸´: 3
µ±Ç°Ö÷ÌâÒѾ­´æµµ¡£
±¾Ìû²úÉú 1 ¸ö ·­ÒëEPI £¬µã»÷ÕâÀï½øÐв鿴

szxxck

ľ³æ (ÕýʽдÊÖ)

[½»Á÷] ÖØ½ðÇóÖú¸ßÈË·­ÒëÒ»¶ÎÕªÒª£¨·ÇGoogle»ò·­ÒëÈí¼þ·­Ò룩

±¾ÎĺϳÉÁËһϵÁÐÑôÀë×Ó·ú±íÃæ»îÐÔ¼Á, N-[3-(¶þ¼×»ù°·»ù)±û»ù]È«·úÍé»ù»Çõ£°·ÑÎËáÑÎ(CnF2n+1SO2NH(CH2)3NH(CH3)2+Cl¨C, n = 6, 8, ·Ö±ð¼ò³ÆÎªPFH-MCºÍPFO-MC), ²¢ÓõÎÌå»ý·¨²â¶¨25 ◦C¡¢pH 2.6~2.7ʱ¸ÃÀàÎïÖʵĵ¥Ìåϵ¼°¼ÓÑκó([NaCl] = 0.1 mol•L-1)µÄ±íÃæÕÅÁ¦ÇúÏß¡£½áºÏÉÏÊöPFB-MCµÄ½á¹ûÌÖÂÛ·Ö×ӽṹÖÐ̼·úƬ¶ÏµÄÁ´³¤¶ÔË®ÈÜÒºÖбíÃæ»îÐÔµÄÓ°Ïì¡£¶Ô±È½ºÍÅÐγÉÄÜÁ¦¡¢½µµÍ±íÃæÕÅÁ¦µÄÄÜÁ¦¡¢±íÃæÎü¸½×´¿öºÍËáÐÔÌõ¼þµÄÇ¿ÈõÓ°Ïì±íÃæ»îÐÔ¼ÁÊÊÓÃÇé¿öµÄ½á¹û±íÃ÷ÒÔϽáÂÛ¡£Ê×ÏÈ£¬Ëæ×ÅÁ´³¤µÄÔö¼ÓÁÙ½ç½ºÊøÅ¨¶È(cmc)¼õСµ«±íÃæÎü¸½Á¿½µµÍ(µ¥·Ö×ÓÎü¸½Ãæ»ýÔö´ó)£»µ¥Ìåϵ×îµÍ±íÃæÕÅÁ¦(¦Ãcmc)PFH-MC×îС(15.02 mN•m-1)£¬PFO-MCµÄ¦ÃcmcºÍPFH-MCÏà±ÈÂÔÓÐÉÏÉý¿ÉÀí½âΪ³¤Á´±íÃæ»îÐÔ¼ÁµÄÈܽâÐÔµÄÏÞÖÆ»òÕ߿ռäÅÅÁеÄÓ°Ïì¡£Íâ¼ÓÑÎÄܽµµÍÌåϵµÄcmc£¨Õâ¿ÉÒÔͨ¹ýÔö¼Ó̼Á´µÄÊèÈܼÁÐÔÖÊÀ´½âÊÍ£©µ«ÓÉÓÚÑÎËá¹ýÁ¿ÈÜÒºÖÐÏ൱ÓÚÒѾ­´æÔÚÒ»¶¨Á¿µÄµç½âÖÊÀ´ÆÁ±ÎÍ·»ùµçºÉµÄÅų⵼Ö¶ԦÃcmcδ¹Û²ìµ½Ó°Ïì¡£ÌÖÂÛÁËÁ´³¤±ä»¯¶ÔÑÎЧӦµÄÓ°Ï죬ÕâÖÖÓ°Ïì³ÊÏÖ²»¹æÔòµÄ±ä»¯£¬PFH-MCËùÊܵÄÑÎЧӦ´ÓijÖ̶ֳȱíÏÖ×îÃ÷ÏÔ¡£Õâ¿ÉÄÜÊÇÓÉÓÚ̼Á´³¤¶ÈPFH-MC×îÊÊÖУ¬¶øPFO-MCºÍPFB-MC¹ý³¤¡¢¹ý¶ÌµÄ̼Á´¼´ÊèË®ÐԽϴó»ò½ÏС¶¼Ê¹µÃÍâ¼ÓNaCl´øÀ´µÄÊèÈܼÁЧӦ¼õС¡£Ñо¿Á˱íÃæ»îÐÔ¼ÁÔÚcmcǰºóµÄ±íÃæÕÅÁ¦ËæpHµÄ±ä»¯¡£
      ±¾ÎÄÑо¿Ö¤Ã÷Á˸ÃϵÁÐÒÔÈ«·úÍé»ùΪ»ù´¡µÄ¡¢º¬ÓÐ̼ÇâÆ¬¶ÎµÄÑôÀë×ÓÐÍ·ú±íÃæ»îÐÔ¼ÁÊÊÓÃÓÚÇ¿ËáÐÔ»·¾³¡¢¿¹ÑΡ¢ÇÒ¾ßÓм«¸ßµÄ±íÃæ»îÐÔ£¬ÎÒÃǶÔʵ¼ÊÑ¡Ôñ½øÐÐÁË×ÛºÏÆÀ¼Û£º¸ÃÀà±íÃæ»îÐÔ¼ÁÊÊÓÃÓÚÇ¿ËáÐÔ»·¾³²¢ÇÒ²»Ò×ÊÜÑζȻ·¾³µÄ¸ÉÈÅ¡£¼ÓÑλ¹ÄÜÃ÷ÏÔ¸ÄÉÆ±íÃæ»îÐÔ¼ÁµÄÐÔÄÜ¡¢½µµÍ¸Ã±íÃæ»îÐÔ¼ÁµÄcmc¡£×ÛºÏÆÀ¶¨Á´³¤µÄÓ°Ïì¿ÉÖª£¬¸ù¾ÝʹÓÃÇé¿ö²»Í¬£¬Èç¹û¶Ô³¬µÍ±íÃæÕÅÁ¦ÒªÇóÑϸñ£¬¿ÉÑ¡Ó÷ú̼ÊýΪ6µÄPFH-MC(×îµÍ±íÃæÕÅÁ¦ÏÔÖøµÍÓÚPFB-MC)£¬ËüÎÞÂÛ´ÓŨ¶È(cmcºÍPFO-MCÏà²î²»ÊÇÌØ±ð´ó£¬Ê¹ÓÃʱËùÐèÁ¿Ð¡)»¹ÊÇʹÓõÄÐÔ¼Û±È(̼·úÁ´¶Ì£¬Éú²ú³É±¾ÓÅÓÚPFO-MC)¿¼ÂǶ¼ÊÇÓÅ»¯µÄ£»Èç¹û¿¼Âǵ½»·¾³±£»¤ºÍÉúÎï½µ½âµÄÒªÇó¶ø¶Ô×îµÍ±íÃæÕÅÁ¦µÄÒªÇóÊʵ±·ÅËÉ£¬¿ÉÑ¡ÓÃPFB-MC¡£

» ²ÂÄãϲ»¶

ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

pharmjackie

ľ³æ (ÕýʽдÊÖ)

szxxck(½ð±Ò+50):лл£¡×¨ÓÐÃû´ÊÎÒÒѾ­¸ÄÁË¡£ 2010-03-29 22:34
A series of cation fluoride surfactant, N-[3-(dimethylamino)propyl]perfluoroalkylsulfonamides hydrochloride (CnF2n+1SO2NH(CH2)3NH(CH3)2+Cl¨C, n = 6, 8 (hereafter referred  to as PFH-MC and PFO-MC respectively) had been synthesized.  The surface tension curve  had been plotted using volume-titration method at a pH of  2.6~2.7 at 25 ◦C for the compound alone and for the system with a salt concentration of 0.1mol/L. The influence the chain length of C-F moiety had on the surface activity of the aqueous solution was discussed with the above results. Comparison of the ability to form micelle, the ability to reduce surface tension, absorbtion state on the surface and the influence acidity had on the application of the surfactant showed that CMC decreased with increasing chain length, with a decreasing absorption capacity due to per-molecular increasing absorption area. The compound alone showed a minimum surface tension, (ycmc)PFH-MC, 15.02 mN/m, while a slight higher surface tension was observed for PFO-MC might be contributed to the solvate limitation that long-chain surfactant had and the steric influence. Additional salt can lower the CMC of the system, which can be explained by its ability to increasing solventphobic forces, but no significant effect had been observed for ycmc because excess hydrochloric acid in the solution might serve as electrolyte to shield capitular charge exclusion forces. The influences chain length had on salt effect was also discussed, which showed irregular alterations with PFH-MC exhibited the most strong salt effect. It might be due to a moderate chain length that PFH-MC had but PFO-MC and PFB-MC had a over-long or over-short chain, i.e. too strong or too weak hydrophobic forces could reduce the hydrophobic effect that additional salt might bring. We also studied how the surfactant¡¯s activity changed with pH.
2Â¥2010-03-29 20:02:18
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

pharmjackie

ľ³æ (ÕýʽдÊÖ)

ÄãµÄժҪ˵ÓÐЩ¿´²»¶®£¬ËùÒÔ·­Òëʱ¿ÉÄÜÓëÄãµÄÒâ˼ÓÐЩ³öÈ룬ÄãÔÙÕå×ÃÕå×á­¡­½¨ÒéÄãÔÙ¿´Ò»ÏÂÄãµÄÖÐÎıíÊö£¬ÊÇ·ñÓÐÐèÒªÐÞ¸Ä
3Â¥2010-03-29 20:04:20
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

pharmjackie

ľ³æ (ÕýʽдÊÖ)

szxxck(½ð±Ò+50, ·­ÒëEPI+1):лл£¡ 2010-04-18 17:15
The results showed that this series of perfluoroalkyl cationic fluoride surfacetant is applicable to strong acid conditions, resistant to salt and with high surfaceactivity. (´ËºóÒ»¾äÎÒ¸øÊ¡ÁË£¬Í¬Ç°Ò»¾ä»ù±¾ÊÇͬÒâ)¡£ Addition of salt could improve the surfactant¡¯s performance significantly, reducing the CMC of the surfactant. Taking the chain length influences into consideration, the six F-C numbered PFH-MC is the first choice with a comparable CMC with PFO-MC but a lower dose, and lower produce-cost than PFO-MC due to shorted C-F chain, while PFB-MC is the best choice when environment-protection and bio-degrade is taken into account.
4Â¥2010-03-29 20:19:19
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ szxxck µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] 413Çóµ÷¼Á +4 ¿Âijij 2026-03-31 4/200 2026-04-04 22:18 by ѧԱ6BFVa3
[¿¼ÑÐ] 0835ѧ˶299Çóµ÷¼Á 08´óÀà¿É½ÓÊÜ +5 useryy 2026-04-03 5/250 2026-04-04 20:07 by À¶ÔÆË¼Óê
[¿¼ÑÐ] 298Çóµ÷¼Á +5 zzz£¬£¬r 2026-04-02 8/400 2026-04-04 19:55 by À¶ÔÆË¼Óê
[¿¼ÑÐ] µç×ÓÐÅÏ¢µ÷¼Á½»²æÑ§¿ÆÓÐÍÆ¼öÂð +6 jhtfeybgj 2026-04-01 8/400 2026-04-04 07:52 by 1753564080
[¿¼ÑÐ] Çó²ÄÁϵ÷¼Á£¬Ò»Ö¾Ô¸Ö£ÖÝ´óѧ289·Ö +15 ˶ÐǸ° 2026-04-03 15/750 2026-04-04 01:01 by userper
[¿¼ÑÐ] 303Çóµ÷¼Á +10 DLkz1314. 2026-03-30 10/500 2026-04-03 18:03 by Jimmyandyou
[¿¼ÑÐ] 372·Ö²ÄÁÏÓ뻯¹¤£¨085600£©Ò»Ö¾Ô¸ºþÄÏ´óѧÇóµ÷¼Á +3 À¶¼ãƬ 2026-04-03 4/200 2026-04-03 17:58 by Jimmyandyou
[¿¼ÑÐ] Ò»Ö¾Ô¸ÉúÎïÓëÒ½Ò©£¬296·Ö£¬Çóµ÷¼Á +8 66¹ 2026-04-03 9/450 2026-04-03 14:22 by »¯Ñ§»¯¹¤Ë¶Ê¿ÕÐÉ
[¿¼ÑÐ] Çóµ÷¼Á +9 akdhjs 2026-03-31 11/550 2026-04-03 13:32 by akdhjs
[¿¼ÑÐ] ר˶ 351 086100 Ò²ÊÇ¿¼µÄ²Ä¿Æ»ù ±¾¿ÆÒ²ÊDzÄÁÏ +8 202451007219 2026-04-02 8/400 2026-04-03 09:50 by À¶ÔÆË¼Óê
[¿¼ÑÐ] Çóµ÷¼Á£¡ÉúÎïÓëҽҩר˶ +4 Äæ×ªÂ½ÏÈÉú 2026-04-01 5/250 2026-04-03 08:33 by Jaylen.
[¿¼ÑÐ] Ò»Ö¾Ô¸aÇø211£¬085601-307·ÖÇóµ÷¼Á +13 µ³¼ÎºÀ 2026-03-31 26/1300 2026-04-03 08:33 by 495374996
[¿¼²©] É격ÇóÖú +3 Reee1Llll 2026-04-01 3/150 2026-04-02 22:29 by ÕâÊÇÒ»¸öÎÞÁĵÄê
[¿¼ÑÐ] ѧ˶»¯Ñ§¹¤³ÌÓë¼¼Êõ£¬Ò»Ö¾Ô¸Öйúº£Ñó´óѧ320+Çóµ÷¼Á +8 ÅûÐÇºÓ 2026-04-02 8/400 2026-04-02 14:12 by oooqiao
[¿¼ÑÐ] 08¹¤¿ÆÇóµ÷¼Á290·Ö +5 1314Åõ»¨ 2026-04-02 8/400 2026-04-02 13:16 by ÇÇßÕßÕßÕ
[¿¼ÑÐ] Ò»Ö¾Ô¸9³õÊÔ366 ±¾Ë«·ÇÇóµ÷¼Á +4 ÔËÆøÀ´µÃÈôÓÐËÆÎ 2026-04-02 4/200 2026-04-02 09:56 by guanxin1001
[¿¼ÑÐ] 286Çóµ÷¼Á +5 Sa67890. 2026-04-01 7/350 2026-04-01 19:50 by 6781022
[¿¼ÑÐ] ÉúÎïÓëÒ½Ò©¿¼Ñе÷¼Á +5 Ìúº©º©123425 2026-03-31 5/250 2026-04-01 18:01 by syh9288
[¿¼ÑÐ] Çóµ÷¼Á£ºÒ»Ö¾Ô¸£ºÄϾ©´óѧ רҵ£º0705 ×Ü·Ö320 £¬±¾¿Æ985£¬ËÄÁù¼¶Òѹý +3 lfy760306 2026-03-31 3/150 2026-04-01 01:57 by Creta
[¿¼ÑÐ] Çóµ÷¼Á ÉúÎïѧ 377·Ö +6 zzll03 2026-03-31 6/300 2026-03-31 17:33 by ÌÆãå¶ù
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û